PEF treatment registry for follow-up care
Part of Skin clinical trials.
This study collects information about people who receive a type of device-based electrical treatment (PEF) using Galvanize technology. It helps researchers understand outcomes after treatment by tracking follow-up data during routine care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having—or already had—PEF treatment using the Galvanize device
- Your doctor expects to be able to follow up with you using their usual care plan
- If enrolling ahead of time: you are expected to live at least 3 months
- If enrolling after treatment: you have had at least 3 months of follow-up imaging
- You agree to participate (sign consent if your hospital requires it)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment that uses short electrical pulses (pulsed electric field ablation) to destroy small lung tumors. It may be an option for people with limited, early-stage non-small cell lung cancer who can tolerate a minimally invasive procedure.
This trial tests a new treatment that uses short electric pulses (pulsed electric field) to target and damage cancer cells in the esophagus. It is for people with advanced esophageal cancer that cannot be removed by surgery, and it aims to be safe and potentially shrink or slow the tumor.
This trial tests a new way to treat breast cancer that has spread to the skin or just under the skin. It uses short electric pulses to target tumors without cutting. The goal is to see if this approach can safely destroy cancer cells in those spots.
This registry is collecting information to see how well the Farapulse PFA system works and how safe it is for treating atrial fibrillation (AF), a common heart rhythm problem. If you are scheduled to have an ablation for AF with this system, this study will follow your progress.
This study tests a new device that uses brief electrical pulses (pulsed electric field or PEF) to treat lung tumors before they are surgically removed. The goal is to see if this approach can be safely added to standard lung cancer surgery.
This registry study collects information from people with atrial fibrillation (an irregular heartbeat) who are having a procedure using the PulseSelect PFA system. It helps doctors understand how well this treatment works in real-world settings.
Hear when a new Soft Tissue Lesion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.